Pfizer breast cancer drug succeeds in mid-stage trial
(Reuters) - Pfizer Inc's experimental breast cancer drug significantly delayed progression of symptoms in a mid-stage trial, meeting the study's prima...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/4Z1N20M4y-E/story01.htm
No comments:
Post a Comment